Bulletin
Investor Alert

London Markets Close in:

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

Market open

/zigman2/quotes/210324360/composite

$

153.98

Change

+4.02 +2.68%

Volume

Volume 76,248

May 17, 2022, 11:19 a.m.

Real time quotes

/zigman2/quotes/210324360/composite

Previous close

$ 149.96

$ 153.98

Change

+4.02 +2.68%

Day low

Day high

$151.43

$154.91

Open
Open: 153.48

52 week low

52 week high

$137.21

$327.32

Open

Market cap

$8.31B

Average volume

546,814

P/E ratio

60.39

Rev. per Employee

$396,381

EPS

2.52

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. Repligen stock price target cut to $230 from $320 at Stifel Nicolaus

    9:01 a.m. Feb. 18, 2022

    - Tomi Kilgore

  2. Repligen stock price target raised to $335 from $255 at KeyBanc Capital

    6:15 a.m. Sept. 17, 2021

    - Tomi Kilgore

  3. How a 53-Year-Old Growth Fund Takes the Long View

    3:05 p.m. Nov. 29, 2021

    - Barron's Online

  4. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    8:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  5. Small-Cap ‘Darlings’ Are Perking Up in 2020

    11:47 a.m. Jan. 21, 2020

    - Barron's Online

  6. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    7:28 a.m. July 13, 2019

    - Philip van Doorn

  7. Repligen started at overweight with $42 stock price target at J.P. Morgan

    8:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  8. Repligen stock fair value estimate raised to $47 from $42 at Janney

    11:26 a.m. June 23, 2017

    - Tomi Kilgore

  9. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    7:01 a.m. June 23, 2017

    - Tomi Kilgore

  10. Repligen's stock halted for news pending

    6:58 a.m. June 23, 2017

    - Tomi Kilgore

  11. Repligen's stock was inactive premarket prior to trading halt

    6:59 a.m. June 23, 2017

    - Tomi Kilgore

  12. Investing From the Ground Up

    12:13 a.m. Sept. 15, 2016

    - Barron's Online

  13. Why Danaher’s Purchase of Pall Means More M&A is on the Way

    11:39 a.m. May 13, 2015

    - Barrons Blogs

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. Revisiting Repligen

    11:31 a.m. May 11, 2022

    - Seeking Alpha

  2. LRT Capital Management March 2022 Investor Update

    10:05 p.m. May 5, 2022

    - Seeking Alpha

  3. Why Repligen Is Up More Than 10% Today

    12:10 p.m. April 27, 2022

    - Motley Fool

  4. Repligen (RGEN) Beats Q1 Earnings and Revenue Estimates

    8:45 a.m. April 27, 2022

    - Zacks.com

  5. Repligen Q1 2022 Earnings Preview

    1:52 p.m. April 26, 2022

    - Seeking Alpha

  6. Notable earnings before Wednesday's open

    10:51 a.m. April 26, 2022

    - Seeking Alpha

  7. 2 Reasons to Buy Repligen, and 1 Reason to Sell

    10:37 a.m. April 14, 2022

    - Motley Fool

  8. 2 Top Biotech Stocks to Buy for the Long Haul

    10:30 a.m. April 7, 2022

    - Motley Fool

  9. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  1. Repligen to Report First Quarter 2022 Financial Results

    7:30 a.m. April 13, 2022

    - GlobeNewswire

  2. Regeneron Drug Could be Less Effective vs. Omicron

    11:12 a.m. Nov. 30, 2021

    - Baystreet.ca

  3. IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

    8:26 p.m. Nov. 11, 2021

    - GlobeNewswire

  4. Repligen Releases Inaugural Sustainability Report

    8:00 a.m. Nov. 5, 2021

    - GlobeNewswire

  5. Repligen to Report Third Quarter 2021 Financial Results

    7:30 a.m. Oct. 14, 2021

    - GlobeNewswire

  6. Repligen Announces Agreement to Acquire Avitide Inc.

    7:41 a.m. Sept. 16, 2021

    - GlobeNewswire

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.